Ms Padron Vega had also been found to have failed in her duties as an OV by being unprepared for, and unaware of, new regulations. She also did not take adequate steps to ensure that the two individuals for whom she had given veterinary certification were licensed to perform slaughter in accordance with the regulations.
Ms Padron Vega originally applied for restoration in December last year, at which time the Disciplinary Committee had concerns about her keeping up-to-date with the knowledge and skills needed to return to practice, and decided to adjourn for six months to allow her to prove that it was appropriate to restore her name to the Register.
At the latest hearing, Ms Padron Vega sought to address the concerns that the Committee had raised about her professional development. In addition to the documentation she provided in her original restoration hearing, which included positive testimonials from colleagues, she provided evidence of her continuing professional development (CPD).
This included a letter from her previous employer, who confirmed she had more recently worked for them as a Certification Support Officer from February to March 2021, where they received positive feedback on her conduct.
The documentation also included a letter from another practice confirming that Ms Padron Vega had been offered a position of employment with them, and a separate letter from practice veterinary surgeon, Dr Khan MRCVS, confirming that he would be her mentor. Dr Khan also confirmed that she had been coming to the practice for work experience and he considered her to have good working knowledge of current medicines used within the practice. He further outlined in his letter what CPD support the practice would be providing for Ms Padron Vega as part of her employment with them.
An additional piece of evidence was a testimonial from Dr Max Rutana MRCVS who confirmed that Ms Padron Vega had worked unsupervised for a period of three weeks, and that he found her clinical notes during this period to be satisfactory and they received no complaints about her conduct from clients.
Ms Padron Vega also submitted CPD documentation which confirmed she has taken a Certification Support Officers’ course and examination in mid-December 2020.
In response to questions from the Committee about her small animal practice experience and how long she had been shadowing Dr Khan for, Ms Padron Vega explained that she had completed 80 hours of shadowing with Dr Khan and that in her future employment under his mentorship, he would be available to support her. She also explained that her job offer was evidence that she would continue to be trained in the relevant area of veterinary work.
Cerys Jones, chairing the Disciplinary Committee and speaking on its behalf, said: “During the hearing, we heard evidence from Dr Khan who provided reassurance of Ms Padron Vega’s continued professional development with his practice and the ongoing supervision that she would be under. He explained that the supervision would last at least three months.
“The Committee’s view is that Ms Padron Vega accepts the findings of dishonesty that were made against her at the original Inquiry hearing. In her Reflective Statement, she acknowledges that veterinarians have a professional responsibility to ensure the integrity of veterinary certification, that she is now aware that when signing documents as a veterinary surgeon they need to be approached with care and accuracy. Further she has undertaken a CPD course on this very ethical issue and has passed the examination set at the end of that course. The Committee is confident that Ms Padron Vega is unlikely to repeat the conduct which resulted in her being removed from the Register. It is the Committee’s decision that she should be restored to the Register.”
The lectures, which are sponsored by Pinmoore Animal Laboratory Services, aim to dispel many of the myths associated with anaesthetising a wide variety of exotic species, including fish and amphibians, whilst simultaneously providing vets and nurses with the skills to undertake these often challenging and comparatively high-risk anaesthetics.
Techniques, protocols, potential drug options and combinations as well as blood sampling and hospitalisation techniques for a wide variety of exotic species will be discussed at length.
Delegates will also get lecture notes, a CPD certificate, goodie bags, refreshments and lunch, not to mention the chance to discuss the day's content with Sonya,
To book your place or for more information, please email us via info@justexotics.co.uk.
Environmental household flea spray, Acclaim®, is now licensed to kill house dust mites. A common cause of allergies, house dust mites are present all year around, aggravating conditions such as atopic dermatitis.
Containing S-methoprene and permethrin, Acclaim is a fast-acting, odourless household spray which kills fleas and flea larvae and has 12 months' activity against flea egg development. It also kills ants, cockroaches, ticks and spiders and does not break down in sunlight in the home.
For information on CEVA Animal Health's complete range of household flea treatments, which includes the traditional pesticide sprays Acclaim® and Staykil® and the innovative non-pesticide product Skoosh®, please contact your local CEVA account manager.
Axiom Veterinary Laboratories is launching MiLab, a new range of in-practice analysers at the BSAVA Congress.
Axiom says the range will be supported with a comprehensive range of additional services, from installation and training through to technical support and maintenance.
Martyn Carpenter, Managing Director of Axiom Veterinary Laboratories said: "An increasing number of UK veterinary practices are opting to carry out a higher proportion of laboratory testing in-house but, in order to do this successfully, they need equipment which is reliable, cost-effective and easy-to-use. Two products in the MiLab range will be showcased at BSAVA, both of which have been selected following extensive validation and correlation testing in Axiom's veterinary laboratories."
The two new products are:
Martyn said: "Investing in significant new equipment is always challenging for practices and we have spoken to many over the last 18 months to understand their experience of and current requirements for in-house analysis and, in particular, the level of support they receive. Practices working with us can be confident that we are offering the very latest in analyser technology, which has been tested rigorously for reliability, economy and ease of use. They can also feel secure in the knowledge that we provide a high level of service and support, delivered by our own highly skilled laboratory technicians."
For more information, contact Steve Clarke at Axiom on 01626 357756.
The WSAVA is calling on veterinary surgeons around the world and anyone with an interest in veterinary – and human – medicine to sign the petition to ensure access to ketamine in the face of lobbying by some countries, principally China, to have it put under international scheduling.
According to the WSAVA, proposals for international control stem from the misconception that ketamine is merely a 'recreational drug.' The WSAVA says this is inaccurate and devalues its huge contribution to human and animal medicine.
Dr Walt Ingwersen, WSAVA President Elect and Member of the WSAVA’s Global Pain Council, said: "In 2015, the WHO Expert Committee on Drug Dependence (ECDD) stated that the abuse of ketamine does not cause a global public health threat and that control would limit access for those using it as an anaesthetic. This view was confirmed at a meeting of the UN Commission on Narcotic Drugs in March 2016, helped by strong support view from the global medical and veterinary communities. However, China has repeated its view that ketamine should fall under international scheduling and we have no doubt that it will raise the issue again. This mean the risk to ketamine remains."
He added: "Ketamine is a safe anaesthetic which can be used without oxygen, ventilators, electricity and the support systems required for other products, making it the only anaesthetic suitable for both medical and veterinary use in lower and middle income countries. If developing countries were denied access to it, which would be the effect of international scheduling, the effects on veterinary medicine, human health and animal welfare would be devastating."
Dr Ganga de Silva, President of the Society of Companion Animal Practitioners of Sri Lanka, said: "Sri Lanka is a poor country with an underdeveloped veterinary profession. If ketamine was not available, in my opinion, all surgeries would have to cease as almost all of the veterinarians in the country rely on it for anaesthesia. The result would be suffering for animals and it would also seriously impact our ability to control rabies as we would not be able to carry out spay and neuter programs on stray dogs."
Dr Nancy Shaffran CVT, VTS(ECC), President of the International Veterinary Academy of Pain Management, said: “In addition to its use as an anaesthetic agent, ketamine is a critical medication used in the pain management in animals. The mechanism of action of ketamine (NMDA receptor antagonism) delivered as a Constant Rate Infusion has been well established to be effective in the prevention and correction of severe neuropathic pain and spinal cord wind-up. The loss of ketamine in veterinary practice would result in the needless suffering of many patients and we strongly oppose this action. We are very grateful for WSAVA’s efforts to keep ketamine available for our patients."
Dr Walt Ingwersen added: "Ketamine is also used in human medicine as it has a particular value for use 'in the field' - for instance, in treating trauma patients, those with traffic and sporting injuries or affected by natural disasters and conflict. Taking these factors together, it is clear that ketamine is an essential medicine and we are determined to ensure that it remains freely available. We are continuing to harness our global veterinary community to highlight the importance of ketamine because this is a battle our patients can’t afford us to lose. We ask all those agreeing with to sign our petition and help our collective voice grow."
The petition is here: http://chn.ge/1RFSou6.
The WSAVA’s Global Pain Council has produced a range of tools and resources, including an infographic, to support its ketamine campaign. They can be accessed here: http://www.wsava.org/educational/global-pain-council
CEVA Animal Health has announced that its live enzootic abortion vaccine, CEVAC® Chlamydophila, now has an added benefit. It can be used simultaneously with the only available toxoplasmosis vaccine. According to CEVA, infectious abortion, particularly enzootic abortion (Chlamydiosis), has been known to wipe out up to 50% of lambs. Strategic use of CEVAC® Chlamydophila, a live enzootic abortion vaccine, can not only prevent abortion but can also control excretion and the threat of infection.
The company says: "CEVAC® Chlamydophila makes practical and economic sense. A vaccination every four years will help your clients’ flocks remain chlamydiosis-free and the cost of treatment should work out at well under 75p per sheep per year. This is a tiny investment for your clients, to prevent the financial loss of an abortion. The fact that the product can now be used on the same day as the toxoplasmosis vaccine means that is now one of the most convenient and affordable methods currently available."
Ideally routine preventative measures should be taken prior to mating and when new sheep are introduced to the flock, to ensure abortion and infection rates always remain as low as possible.
All animals should be vaccinated in the first year, with replacements being vaccinated from six months of age, at least four weeks prior to tupping.
CEVAC® Chlamydophila is quick and easy to administer, using the special, multi-dose injector gun. One bottle of vaccine contains enough for 20 doses.
For further product information contact your local CEVA representative or CEVA Animal Health Ltd, 90 The Broadway, Chesham, Bucks, HP5 1EG or visit the website at http://www.ceva.uk.com/
Petplan, the pet insurance provider has been selected as a Which? Best Buy. The independent consumer guide selected Petplan's 'Covered For Life' policy that covers animals for accidents and illnesses, including reoccurring conditions, such as diabetes and glaucoma, year after year, as long as the policy is renewed annually.
Alison Andrew, Petplan's Marketing Manager said: "The Which? report is crucial to being acknowledged as a worthy pet insurance provider. We feel being selected as a Which? Best Buy reflects how we treat our customers by offering excellent customer service, paying claims quickly, discounts on pet products and regular information about pet care through our magazine PetPeople."
Petplan provides insurance cover for dogs, cats, rabbits and horses and is the largest provider of animal health insurance in the world.
The Vet Futures Action Plan included a series of 24 work-streams to be completed over five years (2016-2020), building on the six core themes of: animal health and welfare; veterinary professionals’ wider roles in society; the health and wellbeing of veterinary professionals; diverse and rewarding veterinary careers; sustainable businesses and user-focused services; and leadership.
Vet Futures reports that over the last twelve months, key activities have included:
VN Futures
The VN Futures project (Action X of Vet Futures) isolated six ambitions to achieve by 2020, with the shorter time-scale reflecting the faster rate of both turnover and training for veterinary nurses.
A number of development groups have been created, focusing on each of these ambitions and creating specific actions to ensure their completion. Of these:
RCVS President, Chris Tufnell said: "When we launched Vet Futures back in 2014, the scope of the project seemed daunting and some were sceptical of our ability to succeed. However, through a robust process of evidence-gathering, analysis, action planning and now taking action itself, we are starting to make an impact on some of those core areas that are so fundamental to the future of our profession, such as animal welfare, technology, veterinary skills and knowledge, and leadership.
"Our Action Plan set out a five-year timeframe and we have made some really excellent progress in year one. This will form the foundation of work yet to come – although it remains important to ensure we scan the horizon for new issues that will have an impact on the profession, navigating our way through challenges as they arise."
BVA President Gudrun Ravetz added: "The excitement was palpable at the Vet Futures Summit last year and it spurred us on to roll up our sleeves immediately to start working on the Action Plan, and so a lot has been achieved already.
"Many of the actions are interlinked and so BVA, RCVS and the VSC are working closely together to oversee their delivery, but we have been particularly pleased at the high level of engagement and enthusiasm from others. The success of Vet Futures will be in the profession coming together to bring about the changes we need for a sustainable future.”
For those new to the club, the idea is that every two weeks, we pick an article in Veterinary Practice and invite the author to join us on VetSurgeon.org, so that you can ask questions and discuss the subject with one another.
As a bonus, you can claim time spent reading or participating in the discussion towards your annual CPD requirement (press the claim CPD button at the top right of the discussion thread).
For this first discussion of 2023, author Andy Yale, an RCVS and European Veterinary Specialist in Small Animal Oncology and Lecturer in Veterinary Oncology at the RVC, will be joining us for a week to answer questions about 'Diagnosis and treatment of common canine oral tumours'.
To take part, first read Andy's article here: https://www.veterinary-practice.com/article/common-canine-oral-tumours.
Then come and join the VetSurgeon Clinical Article Club and post your questions or discussion points here: https://www.vetsurgeon.org/associations/vetsurgeon-clinical-article-club/
VetSurgeon.org Editor, Arlo Guthrie said: "I hope lots of you will come and join in. It really is a great opportunity to learn from specialists and from each other in a professional, moderated forum, where you can be confident of a friendly welcome.”
To find out about the RVC’s internationally recognised veterinary oncology team and the services it offers, visit: https://www.rvc.ac.uk/small-animal-vet/specialist-referrals/clinical-services/veterinary-oncology
A new Support Services Guide has been launched by Fort Dodge Animal Health, designed as an aid to the company’s Practice Support Programme. The guide has been designed to provide a comprehensive reference on all the services Fort Dodge offers its practice customers. These include a comprehensive range of client materials, such as pet healthcare records, reminder stationery and pet health information leaflets, as well as various business support initiatives such as the well-respected Fort Dodge (FDI) bench-marking facility, a vaccine amnesty package and Practice PR. This press relations service provided via a professional PR agency has assisted a number of practices with local publicity, helping them increase their visibility in the local community.
Practices wishing to obtain a copy of the new guide should contact Fort Dodge on 01489 774249.
The CMA says its main concerns remain the same as it outlined in March, namely whether consumers are getting enough information to make informed decisions, whether corporatisation is stifling competition in certain areas, whether corporate groups have incentives to act in ways that reduce choice, whether pet owners might be overpaying for medicines and whether the regulatory framework is outdated
Sarah Cardell, Chief Executive of the CMA, said: "The message from our vets work so far has been loud and clear – many pet owners and professionals have concerns that need further investigation.
"We’ve heard from people who are struggling to pay vet bills, potentially overpaying for medicines and don’t always know the best treatment options available to them.
"We also remain concerned about the potential impact of sector consolidation and the incentives for large, integrated vet groups to act in ways which reduce consumer choice.
"In March we proposed that a formal market investigation was the best route to fully explore these concerns and, if appropriate, take direct action to address them.
"That proposal has been overwhelmingly endorsed through our consultation.
"While we’re aware of acute staff shortages and difficult working conditions for vets, we consider a formal market investigation is essential to ensure good outcomes for the millions of pet owners in the UK as well as professionals working in the sector.
"The independent inquiry group will now take this investigation forward and, in the meantime, we’re publishing some tips to help pet owners better navigate vet services."
Meantime, the CMA has published 3 tips for pet owners, which are to look further than their nearest vet, to question treatment options and to consider buying medication elsewhere.
There are still locum and permanent vacancies in the veterinary industry, despite the current UK recession, but candidates must be prepared to be more flexible, advises veterinary recruitment company, Rig Vet Recruitment.
"The number of vacancies we are being asked to fill at present has not really varied from the same time last year," Said Justin Carpenter, Managing Director of Rig Vets. "But, in these current uncertain times, I would suggest that candidates try to be more versatile in their job requirement criteria on such as location, on-call work, night and weekend duties, working away from home etc, then it will be much easier for us to find them the right positions."
The British Veterinary Association and its specialist cattle division the British Cattle Veterinary Association have welcomed today's announcement by Defra that it is strongly minded to include a controlled cull of badgers as a key component of the bovine tuberculosis (TB) eradication plans for England.
The two associations have long supported the need to control TB in both cattle and wildlife, including the need for a targeted, humane cull of badgers in specific parts of the country.
Following a consultation exercise which closed in December 2010, Defra has today announced:
The BVA and BCVA jointly responded to Defra's 2010 consultation to say that the available science supported the case for a badger cull, alongside the need for stricter cattle control measures, in those areas where badgers are regarded as a significant contributor to the persistent presence of TB. The response also emphasised strongly that any cull of badgers had to be done in a humane and effective manner.
The BVA and BCVA say that today's announcement shows Defra has listened closely to their concerns. Through the consultation response the BVA and BCVA raised the issue of the efficacy of an industry-led cull using controlled shooting (as opposed to cage trapping and shooting) and stated firmly that any cull must be monitored for humaneness. Both of these issues have been considered in depth by Defra and appear to have been addressed in the plans.
The associations say they will be looking closely at the detail of the guidance issued today and will be responding to the consultation.
Harvey Locke, President of the BVA, said: "The BVA and BCVA have long argued for a targeted, humane badger cull to be used alongside stricter cattle controls. We believe that failure to tackle wildlife sources of TB infection has prolonged the presence and enhanced the spread of infection in all affected species populations.
"We recognise that this is a very emotive and difficult decision but we believe that the science supports this policy and we support Defra's commitment to tackling this devastating disease.
"We are particularly pleased that this announcement has not been delayed until after the summer recess, which demonstrates the seriousness of the need to tackle TB."
John Fishwick, President of BCVA, added: "We welcome today's announcement which indicates that a humane and carefully targeted cull of badgers can contribute to the control of this dreadful disease.
"We are particularly pleased that the veterinary profession's concerns that any cull must be humane and well monitored appear to have been listened to and we will now study the proposals in detail.
"An industry-led cull will be an enormous undertaking for everyone involved and it is vital that we get the detail right from the outset; for the sake of cattle, wildlife and industry."
Meanwhile, the RSPCA has expressed its devastation at the announcement.
According to the charity, new research has been published which shows that badger culling can more than double the risk of TB infecting cattle1. High-profile voices such as Sir David Attenborough and government adviser Lord John Krebs have also weighed in, saying a cull could "make the situation worse" and be "ineffective".
David Bowles, Director of Communications for the RSPCA, said: "Today is a black day for badgers - a day we have been dreading.
"At a time when the Welsh government has stepped back from a cull, the government in England is slowly shredding its own animal welfare credentials."
The RSPCA says it agrees that action is needed to combat bovine TB in cattle, but does not think action is synonymous with culling. The charity believes that vaccination of badgers, increased levels of testing, improved biosecurity and stricter controls on the movement of cattle are more effective ways of dealing with the problem in the long-term and eradicating bovine TB in cattle for good.
Colin Booty, senior scientist for the RSPCA, said: "The RSPCA is sympathetic to farmers struggling to cope with the effects of this crippling disease and thinks that the problem of bovine TB in cattle needs a sustainable and effective solution.
"But this is not such a solution. We believe that the government have taken the wrong fork in the road with this risky policy.
"This cull will contribute little or nothing to the long-term goal of eradicating TB nationally. Instead it will wipe out huge numbers of this much-loved species, including many animals which are healthy."
1 The New Medical Research Council study came from Imperial College London and were published in the Royal Society Journal Biology Letters. They were based on analysis of data from the 10-year Randomised Badger Culling Trial set up by the Department for Environment, Food and Rural Affairs (Defra) in 1998.
Novartis Animal Health has assumed marketing responsibilities for the joint health supplement Dasuquin in the United Kingdom and Ireland.
Dasuquin is a veterinary formulation developed to deliver advanced cartilage support in dogs. It contains a combination of glucosamine hydrochloride, chondroitin sulphate, avocado/soybean unsaponifiables (ASU), and tea polyphenols. Novartis says these compounds work synergistically to protect the cartilage, thereby playing an important role in supporting and maintaining joint health.
Novartis highlights a 2007 study which, according to the company, demonstrates that the combination of ASU, chondroitin sulphate, and glucosamine hydrochloride delivers incremental benefits compared to the combination of chondroitin sulphate and glucosamine hydrochloride alone.1
Dasuquin is available in flavoured chewable tablets in 80-count containers. Dasuquin is available in two strengths: small-to-medium dogs weighing between 5 and 25 kg and for large dogs weighing over 25 to 50 kg.
Gaynor Hillier, General Manager UK & Ireland Novartis Animal Health said: "This is a fitting addition to our overall orthopaedic health offering for vets and pet owners. Dasuquin brings vets and dog owners advanced joint health support with the next generation of the popular Cosequin family."
Dasuquin is available from Novartis Animal Health in the United Kingdom and Ireland from licensed veterinary wholesalers. For more information on Dasuquin, contact your Novartis Animal Health Territory Manager
Reference:
Biogal’s CEO, Mr Amos Gershony said: "We placed a large effort behind creating these videos, so that our customers could visualize how simple it is to receive a PCR result in 1 hour."
The videos are:
First opinion practices can refer dogs and cats for routine echocardiography, ECG analysis and full cardiac work-up. In addition, orthopaedic and neurological cases referred with a pre-existing murmur, arrhythmia or cardiac condition will also benefit from screening at the centre.
Andrew was awarded the ECVIM-CA diploma in Small Animal Cardiology in 2013 and brings with him a wealth of experience from both referral practice and the pharmaceutical industry. He said: "I am delighted to be joining the expanding team at Hamilton Specialist Referrals. The desire for the team to provide patients, clients and staff with the best experience possible is close to my heart and I'm looking forward to being a part of that journey."
Director, orthopaedic surgery specialist Michael Hamilton, said, "We're excited to welcome Andrew to the team. His expertise and experience will be invaluable for providing a comprehensive cardiology service, not only to our referring practices, but also for our existing caseload where a cardiac problem is suspected."
For more information, visit: www.hamiltonspecialists.vet.
In the most recent Petplan Pet Census, an annual study of pet ownership in the UK, 97% of vets reported that a lack of funds had led to owners choosing euthanasia over treatment.
Whilst some cases are the result of one-off ‘emergency' treatment, manageable long-term conditions are often at the root of much unnecessary euthanasia because owners simply cannot afford the cost of ongoing treatment. Reported increases in pet obesity and diabetes, arthritis and behavioural problems have all been cited in the Pet Census as common causes of increased and ongoing vet bills.
Vets have been reporting a rise in diseases that are related to obesity in companion animals for some time and with the Petplan Pet Census panel of almost two hundred (198) UK veterinary practices reporting that more than one third (36%) of all dogs and one quarter (29%) of cats they treat are obese, the future for many pets looks bleak. More than half (53%) of vets say that cases of cat and dog diabetes are on the increase. Obesity is actually bucking the trend of more historically significant diseases, including kennel cough and feline leukaemia, which are either remaining static or decreasing.
The number of pets with behavioural problems is also on the rise, with more than half of vets (55%) reporting an increase and most (95%) practices offering support for these animals. Effective treatment is not a quick-fix solution and requires changes to the owner's lifestyle and lengthy work with experts in the field.
Petplan Vet of the Year, Brian Faulkner said: "I think it is a common misconception that the predicament forcing pet owners to euthanase their pet is the out-of-the-blue, one-off vet fees for emergencies. But in fact we are noticing that owners whose pets have on-going illnesses such as diabetes and even behavioural problems that are very manageable are being faced with the dreadful decision to have to euthanase than face the ongoing financial burden. It's even more devastating when the owners have actually taken out an insurance policy but the nature of the policy only covers treatment of any one condition for up to one year. I always advise people to make sure their policies do not cap the time period over which any one condition is covered to avoid this very problem as more comprehensive insurers are then unable to offer cover on a pre-existing condition."
Simon Wheeler, Head of Marketing at Petplan, said: "We receive over 8,700 claims per week and of the top ten claims, six could be recurrent manageable conditions, such as diabetes or arthritis - the very animals that are currently most at risk of being euthanased."
Research announced simultaneously by Sainsbury's Finance has reached similar conclusions. Sainsbury's found that:
Sainsbury's believes that there are two main reasons for this tragic problem: advances in veterinary care leading to increased costs, and the large number (55%) of pets that remain uninsured.
Ed's note: Isn't it time that pet insurance became compulsory?
Drontal has renewed sponsorship agreements with councils throughout the UK in a bid to further encourage pet owners to scoop their dogs' poop.
The support will see thousands of council dog bins featuring Drontal branding to promote best practice amongst dog owners and urge them to clean up after their pets.
Dan White, product manager for Drontal, said: "Through our dog bin sponsorship we are highlighting the importance of responsible pet ownership which includes preventing the spread of worm eggs in the environment by scooping poop."
According to Bayer, Drontal is the only wormer that kills every type of intestinal worm commonly found in UK dogs and cats.
For further information please contact your Bayer representative or log on to www.drontal.com.
Husky, a rather aptly named refrigeration company, has announced it is to launch a veterinary vaccine fridge.
According to the company, the new fridge is a specially adapted version of its SS1 model, one of the most popular refridgerators for caterers because of its performance, reliability and durability.
The new unit is designed to ensure the safe storage of a wide range of vaccines at 2º - 8º degrees Celsius. The unit also incorporates an audible door open alarm, failed temperature alarm, and a fail-safe secondary back-up digital display thermometer as an added safeguard.The vaccine refrigerator door includes security lock as standard, and the refrigerant used in manufacture is R600, a highly efficient hydrocarbon refrigerant coolant - CFC-free and a natural non-greenhouse gas.
Geoff Thomasson, Chief Executive of the Husky team of companies said: "The SS1 has long been a winner with the hospitality trade and we believe we will enjoy similar success with this medical version. The potential market is enormous."
For more information, ring 01455 555340 or email: info@husky-global.com
Tip 1 – Make sure that pet owners understand the functions of a microchip properlyMichelle says: "Some customers I’ve spoken to wrongly believe that microchips function as GPS trackers. To help manage pet owners’ expectations I always stress the importance of a microchip in lost pet recovery scenarios, where they serve as a permanent form of identification."
Tip 2 – Stress the importance of pet owners updating their contact details with their microchip providerMichelle says: "Pet owners often think that updating contact details with their vet will automatically sync these changes with the microchip database. It’s vital to inform owners that they must separately update their contact information with their microchip database. I’d recommend regularly reminding pet owners to check and update their microchip registration."
Tip 3 – Reassure pet owners that microchips are safe for their catsMichelle says: "I’ve had some owners express worries about allergic reactions or rejection of the microchip by their cat's body. So it’s worth taking the opportunity to dispel this myth during routine wellness exams by explaining microchips are made from inert, biocompatible materials designed to be nonallergenic and nontoxic.
Tip 4 – Make sure to discuss the longevity of microchips with pet ownersMichelle says: Microchips are designed to last the lifetime of the pet without needing a power source and that their functionality can easily be verified during any veterinary visit. If you find an owner expresses concerns about this, you could offer to check the microchip as part of regular health checks to demonstrate its reliability.
Tip 5 – Emphasise how every cat needs a microchip – regardless of age or activity levelMichelle says: "All vets will know even indoor or elderly cats can escape or wander off and older cats can become disoriented more easily. It is worth reminding owners that microchipping is a safeguard, ensuring their pet can be identified and returned home if lost. The new law means that pet owners can also face a large £500 fine if their cat isn’t microchipped."
Tip 6 – Explain how not all microchips are the same and the importance of getting the right oneMichelle says: I often explain that microchips vary in terms of the technology they employ, such as the new 'Thermochip' by HomeAgain that also measures a cat’s subcutaneous temperature. It’s worth talking pet owners through the different microchips available and the database options so they can make an informed choice.
http://homeagain.co.uk/Cats
Christian Mauricio Gómez Álvarez, founder of VetCam Specialists, said: "This partnership represents a significant step forward in continuing professional development as our participants will receive first-class content and well-prepared,interactive case studies where they can additionally work directly.”
In addition, Veheri offers free access to a global community, where veterinary surgeons can share and discuss diagnostic images and imaging studies.
The company also offers a teleradiology reporting service.
The first joint training courses will be available from November 2024.
vetcameducation.com
www.veheri.com
BCF has launched the CR7, a new dental x-ray system to add to the company's range of digital radiography equipment.
BCF describes the CR7 as a portable, desk-top sized, small format CR X-ray dental system which has been specifically designed for dental diagnosis in a veterinary practice, with intuitive operation and fast workflow integration.
Kat Evans from BCF said: "The image quality on this machine is fantastic. The CR plates are scanned at 25 line pairs per mm, giving over double the resolution of any traditional CR system. This allows for much more accurate diagnosis of dental disease. It can also be used with a normal X-ray generator."
For more information visit www.bcftechnology.com or call +44 (0)1506 460023 to arrange a demonstration. You can also join BCF on Facebook at www.facebook.com/bcftechnology
A research project funded by equine charity The Horse Trust has found that lameness is the most common reason for euthanasing a geriatric horse.
According to the charity, this research is the first in the UK to provide data on the causes of death in geriatric horses. Although post-mortem studies have provided some data regarding causes of death, "old age" was previously reported as a common reason for the euthanasia of adult horses.
The research was carried out by Joanne Ireland at the University of Liverpool and led by Dr Gina Pinchbeck. Ireland surveyed horse owners living in the North-West and Midlands areas of England and North Wales who have a horse aged 15 years or older. 918 owners of geriatric horses were followed in a cohort study and 118 mortalities were reported during the 18 month follow-up period, of which 111 were euthanased.
The researchers found that 24% of horses were euthanased due to lameness; an additional 12% were euthanased due to laminitis - a common cause of lameness. After lameness, colic was the next most common cause of euthanasia, with 21% of owners citing this as the main reason.
In an earlier stage of the project, the researchers had found that half the geriatric horses surveyed suffered from lameness, but only 24% of owners reported the problem.
Dr Pinchbeck said: "Although lameness is common in older horses, this is the first study to quantify its contribution to their mortality.
"Owners are often missing the early signs of lameness in their horse, which means the condition isn't being managed and may deteriorate faster."
Dr Pinchbeck said it would be useful to carry out further research into lameness in geriatric horses to find out the main causes of lameness and how these may be prevented or treated.
The research team also found that half of the horses euthanased were suffering from concurrent health problems and these influenced the owner's decision to euthanase in 43% of cases. The most frequently reported additional health problems were musculoskeletal problems, such as arthritis.
The mortality rate among the horses surveyed was 11 per 100 horse-years at risk, meaning that if 100 geriatric horses were followed for a year, an average of 11 would die. The mortality rate for horses over 30 years of age was over five times the rate than in horses aged 15 - 19 years.
Jeanette Allen, Chief Executive of The Horse Trust, said the data provided by this research is likely to provide useful information for both horse owners and vets to enable them to improve the welfare of older horses. She said: "As there are a significant number of geriatric horses in the UK, it is vital that we understand more about the health problems that affect them. We hope that more owners of older horses will give their horse an annual health-check to enable the horse to have a longer, healthier life."
The research was published in the September 2011 issue of Preventive Veterinary Medicine.
Rimifin (carprofen), an NSAID marketed by Vetoquinol, has been given a new flavour to help increase compliance.
Robert Simpson, Product Manager for Rimifin said: "Pet owner compliance and involvement in chronic pain situations is critical to ensuring effective long term treatment. Ease of administration is also very important in this setting. The addition of this flavouring to this popular and cost effective NSAID will help to ensure that administration to the patient is as easy as possible for pet owners and vets."
To find out more about Rimifin please contact your Vetoquinol Territory Manager or call 01280 825424.
The Animal Health Trust is calling for all small animal practitioners to help with a prospective survey study on breed differences in clinical features in canine hyperadrenocorticism.
The Trust is asking vets that diagnose a case of spontaneous hyperadrenocorticism to complete an online questionnaire at bit.ly/aht-cushing.
The questionnaire should take 10 minutes to complete and all the information will be processed anonymously. Each questionnaire submitted has a chance to win a £100 Amazon voucher. On completing the survey, participants can ask to be notified of the results of this study when available.
Researchers say they hope this data will help veterinary surgeons in the diagnosis of canine hyperadrenocorticism, and ask that everyone helps spread the word about the study.
If you have any queries about this study, please contact michael.bennaim@aht.org.uk